Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

11/04/2021 | 05:34am EST

Item 2.02 Results of Operations and Financial Condition.

On November 4, 2021, Prestige Consumer Healthcare Inc. (the "Company") announced financial results for the fiscal quarter and six months ended September 30, 2021. A copy of the press release announcing the Company's earnings results for the fiscal quarter and six months ended September 30, 2021 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On November 4, 2021, representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter and six months ended September 30, 2021 using slides attached to this Current Report on Form 8-K as Exhibit 99.2 (the "Investor Presentation") and incorporated herein by reference. The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2022.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

The information presented in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

See Exhibit Index immediately following the signature page.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about PRESTIGE CONSUMER HEALTHCARE INC.
01/10Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
AQ
2021PRESTIGE CONSUMER HEALTHCARE : Morgan Stanley Virtual Global Consumer & Retail Conference
PU
2021INSIDER SELL : Prestige Consumer Healthcare
MT
2021DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps..
MT
2021Q2 2022 Prestige Consumer Healthcare Inc. Earnings Conference Call
PU
2021Prestige Consumer Healthcare Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2022 Gui..
MT
2021PRESTIGE BRANDS : Fiscal Q2 Earnings Snapshot
AQ
2021PRESTIGE CONSUMER HEALTHCARE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
2021Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and S..
CI
2021Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results - Form 8-K
PU
More news
Analyst Recommendations on PRESTIGE CONSUMER HEALTHCARE INC.
More recommendations
Financials (USD)
Sales 2022 1 060 M - -
Net income 2022 197 M - -
Net Debt 2022 - - -
P/E ratio 2022 15,4x
Yield 2022 -
Capitalization 2 989 M 2 989 M -
Capi. / Sales 2022 2,82x
Capi. / Sales 2023 2,73x
Nbr of Employees 505
Free-Float 91,6%
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 59,65 $
Average target price 68,00 $
Spread / Average Target 14,0%
EPS Revisions
Managers and Directors
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer
Jeff Zerillo Senior Vice President-Operations
John E. Byom Independent Director
Sheila A. Hopkins Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PRESTIGE CONSUMER HEALTHCARE INC.-1.65%2 989
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.72%323 901
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317